Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126539393 | 12653939 | 3 | F | 20160727 | 20160829 | 20160816 | 20160901 | EXP | IT-009507513-1608ITA007280 | MERCK | 77.00 | YR | F | Y | 0.00000 | 20160901 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126539393 | 12653939 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | UNK | Y | U | 19766 | TABLET | |||||||
| 126539393 | 12653939 | 2 | I | CLEXANE (enoxaparin sodium) | ENOXAPARIN SODIUM | 1 | Subcutaneous | 6000 IU, IN THOUSANDS, DAILY | Y | U | 0 | QD | |||||||
| 126539393 | 12653939 | 3 | I | CARDIOASPIRIN | ASPIRIN | 1 | 100 MG, DAILY | Y | U | 0 | 100 | MG | QD | ||||||
| 126539393 | 12653939 | 4 | I | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | Y | U | 0 | |||||||||
| 126539393 | 12653939 | 5 | C | MADOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 6 | C | RENVELA | SEVELAMER CARBONATE | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 7 | C | EPOETIN ZETA | ERYTHROPOIETIN | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 8 | C | TAVOR (LORAZEPAM) | LORAZEPAM | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 9 | C | HUMALOG | INSULIN LISPRO | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 11 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 13 | C | CETIRIZINE HYDROCHLORIDE. | CETIRIZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126539393 | 12653939 | 14 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | UNK | 0 | ||||||||||
| 126539393 | 12653939 | 15 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126539393 | 12653939 | 2 | Anticoagulant therapy |
| 126539393 | 12653939 | 3 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126539393 | 12653939 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126539393 | 12653939 | Anaemia | |
| 126539393 | 12653939 | Drug interaction | |
| 126539393 | 12653939 | Peritoneal haemorrhage | |
| 126539393 | 12653939 | Spontaneous haematoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126539393 | 12653939 | 1 | 2016 | 0 | ||
| 126539393 | 12653939 | 2 | 2016 | 0 | ||
| 126539393 | 12653939 | 3 | 2016 | 0 | ||
| 126539393 | 12653939 | 4 | 2016 | 0 |